+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 4
Age: 18Years +
FEMALE
Healthy Volunteers
ID05221021

Comparing Vaginal Estradiol Cream and Oral Mirabegron for Treating Overactive Bladder in Postmenopausal Women

Led by Walter Reed National Military Medical Center · Updated on 2024-08-19

152

Participants Needed

1

Research Sites

4 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating treatments for Overactive Bladder Syndrome OAB in postmenopausal women experiencing urinary frequency, urgency, nocturia, with or without urgency urinary incontinence. This condition affects many women over 65 and can impact mental health, sleep, physical activity, productivity, and quality of life. The study compares the effects of vaginal estradiol cream and oral Mirabegron in managing these symptoms. Participants will be randomly assigned to one of two groups for 12 weeks one group will use 0.01% vaginal estradiol cream applied once nightly for two weeks, then three times a week, combined with a daily placebo oral pill the other group will take 50 milligrams of oral Mirabegron once daily with a placebo vaginal cream following the same schedule. After 12 weeks of single therapy, participants can choose to receive both treatments together for an additional 12 weeks. During the study, participants will complete questionnaires about symptom severity, quality of life, and global impressions of severity and improvement. They will keep a 24-hour voiding diary and have their post-void residual measured. Follow-up assessments occur after 12 weeks of single therapy and after the optional combined therapy. The main outcome measured is the change in symptom bother scores after 12 weeks, with additional evaluations on quality of life and urinary symptoms.

CONDITIONS

Brief Title

Vaginal Estradiol vs Oral Beta-3 Agonist for Overactive Bladder Syndrome

Research Team

C

Christopher W Heuer, DO

K

Katherine L Dengler, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here